New York Times Magazine looks at CCSVI: "A Controversial ‘Cure’ for M.S."

[ActiveMSers]

To be published Sunday, Oct 28.

http://www.nytimes.com/2012/10/28/ma...sclerosis.html

[ActiveMSers]

For the MS Society to spend 7% of its budget on CCSVI research because of public demand is eye-opening. That's a lot of research dollars going into one theory. I wrote a letter to the editor. Doubt it will get published, but you never know....